Korner Paul

Avg. Two Year Performance

No purchase track record
84% Avg. Sale Return
36% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return14%7%59%45%84%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Drugs - Generic

Chief Medical Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

EVP, Chief Medical Officer:

Holdings: 72.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--